Literature DB >> 29661544

Renal cell carcinoma for the nephrologist.

Mark A Perazella1, Robert Dreicer2, Mitchell H Rosner3.   

Abstract

Renal cell carcinoma (RCC), a malignancy whose incidence is increasing, is frequently encountered in general nephrology practice when acute and chronic kidney disease occurs in the course of disease. Importantly, when kidney disease develops in the setting of RCC, mortality is significantly increased with patients often dying of a non-cancer-related complication of kidney disease. As such, practicing nephrologists need to have a working knowledge of this cancer's biology, treatment, and complications. Nephrologists should be involved in all aspects of the care of patients with RCC including in the acute setting prior to nephrectomy and in the chronic setting for patients with post-nephrectomy chronic kidney disease and those receiving potentially nephrotoxic anti-cancer agents. This collaborative approach to RCC care will hopefully improve patient outcomes.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; immunotherapy; nephrotoxicity; renal cell carcinoma; targeted anticancer agents; von Hippel-Lindau

Mesh:

Year:  2018        PMID: 29661544     DOI: 10.1016/j.kint.2018.01.023

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.

Authors:  Xin-Qiang Wu; Xi Tian; Fu-Jiang Xu; Yue Wang; Wen-Hao Xu; Jia-Qi Su; Yuan-Yuan Qu; Jian-Yuan Zhao; Hai-Liang Zhang; Ding-Wei Ye
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC.

Authors:  Zhen-Long Wang; Peng Zhang; He-Cheng Li; Xiao-Jie Yang; Ya-Ping Zhang; Zhao-Lun Li; Li Xue; Yu-Quan Xue; Hong-Liang Li; Qi Chen; Tie Chong
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

3.  CircUBAP2 Inhibits Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma via Targeting miR-148a-3p/FOXK2 Pathway.

Authors:  Jiping Sun; Aiping Yin; Wenjing Zhang; Jia Lv; Yu Liang; Huixian Li; Yan Li; Xudong Li
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

4.  Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures.

Authors:  Ying Tong; Yiwen Yu; Hui Zheng; Yanchun Wang; Suhong Xie; Cuncun Chen; Renquan Lu; Lin Guo
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

5.  Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer.

Authors:  Shengwei Tian; Si Sun; Weipu Mao; Siwei Qian; Lei Zhang; Guangyuan Zhang; Bin Xu; Ming Chen
Journal:  Int J Gen Med       Date:  2021-09-01

6.  The impact of muscle mass loss and deteriorating physical function on prognosis in patients receiving hemodialysis.

Authors:  Mineaki Kitamura; Takahiro Takazono; Kosei Yamaguchi; Satoko Notomi; Kenji Sawase; Takashi Harada; Satoshi Funakoshi; Hiroshi Mukae; Tomoya Nishino
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.379

Review 7.  Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.

Authors:  Hye-Won Lee
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

Review 8.  Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy.

Authors:  Ying Wang; Yunjing Zhang; Ping Wang; Xianghui Fu; Weiqiang Lin
Journal:  Mol Cancer       Date:  2020-10-14       Impact factor: 27.401

Review 9.  The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?

Authors:  Alessandra Cinque; Anna Capasso; Riccardo Vago; Michael W Lee; Matteo Floris; Francesco Trevisani
Journal:  Biomedicines       Date:  2021-12-31

10.  CARS as a Prognosis Factor in Clear Cell Renal Cell Carcinoma and Its Association with Tumor Immunity.

Authors:  Quan Meng; Can-Xuan Li; Dan Long
Journal:  Int J Gen Med       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.